National Kidney Foundation

Everly Health and National Kidney Foundation Partnership Aims to Save Lives Through Early Detection of Chronic Kidney Disease

Retrieved on: 
星期一, 二月 5, 2024
Other Health, General Health, Philanthropy, Telemedicine, Virtual Medicine, Biometrics, Hospitals, Health Technology, Fitness & Nutrition, Foundation, Cardiology, Practice Management, Health, Diabetes, Glycated hemoglobin, Partnership, Kidney, National Kidney Foundation, Cholesterol, Knowledge, Prediabetes, National Committee, Quality assurance, Biomarker, UACR, Patient, NCQA, Diagnosis, Collection, Glomerular filtration rate, MBA, Kidney disease, MPH, Hypertension, Risk, CMS, Education, Heart, EGFR, Chronic kidney disease, Medicare, HEDIS, Pharmaceutical industry

“We are excited to partner with Everly Health to expand education on chronic kidney disease and two of its major risk factors, diabetes and hypertension,” said Joseph Vassalotti, MD, Chief Medical Officer at the National Kidney Foundation.

Key Points: 
  • “We are excited to partner with Everly Health to expand education on chronic kidney disease and two of its major risk factors, diabetes and hypertension,” said Joseph Vassalotti, MD, Chief Medical Officer at the National Kidney Foundation.
  • The new test suite includes Heart and Kidney Health Test, Diabetes Monitoring Test, Kidney Health Test, and Heart Health Test as part of preventive care screening.
  • Everly Health Solutions and a national health plan recently launched a kidney health pilot program to distribute Everly Health’s Kidney Health Tests to over 10,000 members.
  • For more information about the Everly Health Solutions diabetes monitoring and kidney health testing suite, visit https://www.everlyhealthsolutions.com/ .

National Kidney Foundation Innovation Fund Invests in ImmunoFree

Retrieved on: 
星期二, 一月 30, 2024
National Kidney Foundation, Growth, Immunosuppression, Research, Patient, Kidney disease, Kidney, Transplant, Longevity, COVID, National Kidney Registry, Quality of life, Risk, Dialysis, Kidney transplantation, Organ transplantation, Health equity, Health, NKF, Cancer, Dentistry

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.

Key Points: 
  • ~
    NEW YORK, Jan. 30, 2024 /PRNewswire/ -- The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund.
  • "In a post COVID world, solving the issues raised by immunosuppressive medications for transplant patients has never been more critical," said Kevin Longino, CEO of the National Kidney Foundation and a kidney transplant recipient.
  • Launched in 2021, the NKF Innovation Fund works to accelerate funding, development, and commercialization of therapies that kidney patients need and deserve.
  • The fund invests in early to mid-stage companies that are developing innovative, patient-centric kidney therapies.

Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones

Retrieved on: 
星期二, 一月 23, 2024
CMC, LOS, Dialysis, Patient, Therapy, International Society of Nephrology, NKF, National Kidney Foundation, ATP, Agency, Hyperphosphatemia, American Journal, Acute kidney injury, Nephrology, Clutch (eggs), ISN, Trial of the century, Society, Kidney disease, Chronic kidney disease, Water, NDA, European Renal Association, HIV/AIDS, CKD, Conditional sentence, Heart, FDA, Tablet, ERA, Letter, Patent, International Society, Mitochondrial disease, Diabetes, Physician, Pharmaceutical industry

LOS ALTOS, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today issued a letter to shareholders.

Key Points: 
  • As I sit down to write this letter, I am filled with a profound sense of gratitude and excitement, energized for the year ahead.
  • In this letter, I am pleased to recap for you another year of great accomplishments.
  • We’ve made significant advancements in our clinical programs which will propel us to new heights in 2024.
  • I would like to express my deep appreciation to the physician investigators, study participants, and especially to our dedicated Unicycive employees.

CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024

Retrieved on: 
星期五, 十二月 1, 2023
Health, Practice Management, Health Technology, Other Health, Health Insurance, Managed Care, General Health, Patient-centered outcomes, ANA, National Kidney Foundation, NKF, ASN, Organization, National Alliance, White, AHIP, Elective surgery, Kidney disease, ACC, American Society of Nephrology, American Academy, American Diabetes Association, Patient, American Occupational Therapy Association, PAM, University, American Nurses Association, American Academy of Neurology, CMS, Patient Activation Measure, AAOS, Doctor of Public Health, NAMI, Doctor of Philosophy, Medicare, Society, AAN, Mental disorder, MVP Arena, AOTA, Human, Nursing, MIPS, Phreesia

The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.

Key Points: 
  • The Patient Activation Measure (PAM) measures a patient’s knowledge, skills and confidence to self-manage their health.
  • Activated patients feel comfortable advocating for themselves and asking for support from their care team to manage their own health.
  • “It’s incredibly gratifying to see CMS include the Patient Activation Measure Performance Measure in its program as a high priority outcome measure.
  • “As a practice that uses the Patient Activation Measure and participates in MIPS, we're incredibly excited to see that PAM will be a MIPS measure going forward.

New Study Finds Significant Impact of Plant-Based Diets on Chronic Kidney Disease Patients

Retrieved on: 
星期五, 十二月 15, 2023
Diet, Chronic kidney disease, Disease, National Kidney Foundation, Research, NKF, AJKD, MHS, Risk, Mortality, Vegetable, Patient, Plant, CKD, Kidney, MPH, Survival, Phosphorus, Public health, Quality of life, Soft drink, Dietary supplement, Pharmaceutical industry, MD, Doctor of Philosophy

NKF's AJKD study reveals that a healthy plant-based diet will reduce the risk of all-cause mortality in CKD patients.

Key Points: 
  • NKF's AJKD study reveals that a healthy plant-based diet will reduce the risk of all-cause mortality in CKD patients.
  • This study suggests that plant-based diets can be a viable and beneficial dietary option for CKD patients.
  • It also emphasizes the importance of dietary quality by distinguishing between overall plant-based diets, healthy plant-based diets, and unhealthy plant-based diets.
  • The study, which involved 2,539 participants with CKD from the Chronic Renal Insufficiency Cohort (CRIC) study, conducted between 2003 and 2008, sheds light on the impact of dietary choices in CKD patients.

NKF Launches Educational 'Animated Video Series for Patients with Lupus and Lupus Nephritis'

Retrieved on: 
星期一, 十二月 4, 2023
Diet, Disease, Woman, National Kidney Foundation, Health literacy, Black, NKF, Immune system, LN, Prevalence, Narration, Alaska Natives, Acute kidney injury, Kidney disease, Risk, Meta-analysis, Mortality, American Indians, Patient, Lupus, Kidney, Music, Comorbidity, Steroid, SLE, Lupus nephritis, Diagnosis, Survival, CDC, Quality of life, Registry, Pharmaceutical industry, Medical device

NEW YORK, Dec. 4, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) has launched a new four-part patient-friendly animated video series to educate and help patients from diverse backgrounds and with varying levels of health literacy better understand the link between systemic lupus erythematosus (SLE) and lupus nephritis (LN). SLE is a chronic, inflammatory autoimmune disease with the potential to affect all organ systems, including the kidneys. Compared to the general population, patients with SLE and LN have an increased risk of mortality.i, ii The cause of SLE remains unknown, but it may be triggered in genetically susceptible individuals by not yet discovered environmental factors.

Key Points: 
  • Both narration and text are simple and easy to understand; all the videos include animations, music, and colorful graphics.
  • The morbidity and mortality of lupus patients who develop kidney involvement are significantly increased compared to lupus patients without kidney disease.
  • vi Data from the New York City registry showed kidney disease was present in over 50% of the non-white patients.
  • Topics for each animated video include the following: lupus nephritis and the kidneys; diagnosis; lifestyle and wellness; and treatments.

National Kidney Foundation Serving Greater New York & CT Appoints Julie Roehm to Board of Advisors

Retrieved on: 
星期二, 十一月 28, 2023
National Kidney Foundation, NKF, Chair, Central Waqf Council, Kidney disease, Patient, Kidney, Region, Marketing, Education, Pharmaceutical industry, Greater New York

NEW YORK, Nov. 28, 2023 /PRNewswire/ -- The National Kidney Foundation serving Greater New York and CT (NKF) proudly welcomes Julie Roehm to its distinguished Board of Advisors. With a wealth of experience in marketing and digital transformation, Roehm's appointment promises to bring invaluable insights to NKF's mission of providing education, support, and resources to individuals grappling with kidney disease across Connecticut and Greater New York.

Key Points: 
  • Renowned Marketer and Living Kidney Donor Brings Expertise to Advance Awareness and Fundraising, Fostering NKF's Giving Tuesday Mission
    NEW YORK, Nov. 28, 2023 /PRNewswire/ -- The National Kidney Foundation serving Greater New York and CT (NKF) proudly welcomes Julie Roehm to its distinguished Board of Advisors.
  • Her wealth of experience, coupled with her personal journey as a living kidney donor, uniquely positions her to champion NKF's cause.
  • "I am honored to join the Board of Advisors at the National Kidney Foundation during this pivotal time.
  • NKF's commitment to saving lives through awareness, prevention, and treatment of kidney disease resonates deeply with Roehm.

NKF's Innovation Fund Invests in ZeitLife to Modernize Kidney Preservation and Logistics

Retrieved on: 
星期四, 十一月 16, 2023
National Kidney Foundation, Health equity, NKF, Strategic Innovation Fund, Entrepreneurship, Kidney disease, Patient, Dialysis, Kidney, Kidney transplantation, Transport, Pharmaceutical industry

NEW YORK, Nov. 16, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is proud to announce its latest investment through the NKF Innovation Fund. ZeitLife™ Transplant Innovations, Inc., is a global medical device company specializing in advancing technologies to modernize kidney preservation and logistics.

Key Points: 
  • ZeitLife™ Transplant Innovations, Inc., is a global medical device company specializing in advancing technologies to modernize kidney preservation and logistics.
  • "We are thrilled to invest in ZeitLife's quest to modernize kidney preservation," said Kevin Longino, NKF CEO.
  • "We are thrilled to invest in ZeitLife's quest to modernize kidney preservation and logistics," said Kevin Longino, CEO of the National Kidney Foundation and a kidney transplant recipient.
  • With the support of the Innovation Fund, we look forward to accelerating the transformation of kidney preservation and logistics, ultimately improving the lives of countless patients waiting for kidney transplants."

US Senate introduces AAIHR-endorsed proposal to address nursing shortage

Retrieved on: 
星期四, 十一月 2, 2023
Education, Physician, American Medical Association, National Kidney Foundation, Legislation, American Health Care Association, American Academy, American Hospital Association, Employment, International healthcare accreditation, Hospital, United States House of Representatives, Senator, United States Department of State, Nursing, Patient, Senate, Pediatrics (journal)

The Senate bill, which boasts an impressive 14 original cosponsors, would recapture 25,000 previously issued but unused immigrant visas for qualified registered nurses and another 15,000 for physicians.

Key Points: 
  • The Senate bill, which boasts an impressive 14 original cosponsors, would recapture 25,000 previously issued but unused immigrant visas for qualified registered nurses and another 15,000 for physicians.
  • "The HWRA is one of the most urgently needed healthcare proposals I've ever seen in thirty years of staffing patient bedsides.
  • The HWRA would address this catastrophic visa freeze by recapturing and reallocating unused green cards from fiscal years when employment-based immigration was lower.
  • This approach would not create any additional green cards, nor would the nurses whose lawful immigration it enables displace any American worker because the nursing shortage is so severe.

DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care

Retrieved on: 
星期三, 十月 18, 2023
Cloud, Medical Affairs Bureau, NYSE, BigQuery, Crash, ESKD, Kidney failure, National Kidney Foundation, Organization, Kidney disease, Google Cloud, Chronic kidney disease, DaVita Inc., Dialysis, Caregiver, IA Financial Group, Machine learning, Hospital, CKD, AI, Google Cloud Platform, Patient, Society for Healthcare Strategy and Market Development, Medical device, Pharmaceutical industry, Nursing

SUNNYVALE, Calif., Oct. 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a new clinical operating system that sets a foundation for streamlined kidney care for more than 200,000 DaVita patients.

Key Points: 
  • Kidney care provider harnesses the power of Google Cloud's leading-edge infrastructure, AI, and analytics tools to help improve care plans and streamline clinical workflows
    SUNNYVALE, Calif., Oct. 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a new clinical operating system that sets a foundation for streamlined kidney care for more than 200,000 DaVita patients.
  • With the deployment, DaVita has moved from a decentralized clinical documentation system to a unified platform that leverages data from more than 30 million dialysis treatments per year to generate insights designed to help improve clinical outcomes.
  • Ultimately, the platform is designed to support DaVita's mission to provide integrated kidney care that helps, improve patient quality of life, and lower the cost of care.
  • A leader in kidney care, DaVita has more than 20 years of clinical data, based on the more than 30 million dialysis treatments the organization administers each year.